Literature DB >> 12963329

Business case for implementing two ergonomic interventions at an electric power utility.

Patricia A Seeley1, Richard W Marklin.   

Abstract

Ergonomics analysis of line workers in the electric power industry who work overhead on utility poles revealed some tasks for which less than 1% of the general population had sufficient strength to perform. During a 2-year study, a large Midwestern US electric utility provided a university with a team of represented workers and management. They evaluated, recommended, and monitored interventions for 32 common line worker tasks that were rated at medium to high magnitude of risk factors for musculoskeletal disorders (MSDs). Two of the recommended ergonomic interventions-the battery-operated press and cutter-were selected by the team as having the greatest potential for reducing risk factors of MSDs. Only overhead distribution line worker tasks were evaluated. A business case was formulated that took into account medical injury and illness statistics, workers' compensation, replacement worker and retraining costs. An outline of a business case formulation and a sample intervention payback calculation is shown. Based on the business case, the utility committed over US dollars 300000 to purchase battery-operated presses and cutters for their overhead distribution line crews.

Entities:  

Mesh:

Year:  2003        PMID: 12963329     DOI: 10.1016/S0003-6870(03)00063-2

Source DB:  PubMed          Journal:  Appl Ergon        ISSN: 0003-6870            Impact factor:   3.661


  2 in total

Review 1.  Practice and potential of economic evaluation of workplace-based interventions for occupational health and safety.

Authors:  Emile Tompa; Roman Dolinschi; Claire de Oliveira
Journal:  J Occup Rehabil       Date:  2006-09

2.  Estimating investment worthiness of an ergonomic intervention for preventing low back pain from a firm's perspective.

Authors:  Richard E Hughes; Nancy A Nelson
Journal:  Appl Ergon       Date:  2008-11-22       Impact factor: 3.661

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.